Abiraterone
The serum concentration of Imiquimod can be increased when it is combined with Abiraterone.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Imiquimod.
Amiodarone
The metabolism of Imiquimod can be decreased when combined with Amiodarone.
Advertisement
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Imiquimod.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Imiquimod.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Imiquimod is combined with Anthrax immune globulin human.
Advertisement
Apalutamide
The serum concentration of Imiquimod can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Imiquimod can be increased when it is combined with Aprepitant.
Atazanavir
The metabolism of Imiquimod can be decreased when combined with Atazanavir.
Advertisement
Atomoxetine
The metabolism of Imiquimod can be decreased when combined with Atomoxetine.
Azithromycin
The metabolism of Imiquimod can be decreased when combined with Azithromycin.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Imiquimod.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Imiquimod is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Imiquimod is combined with Bacillus calmette-guerin substrain tice live antigen.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Imiquimod.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Imiquimod.
Boceprevir
The metabolism of Imiquimod can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Imiquimod can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Imiquimod can be decreased when it is combined with Bosentan.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Imiquimod.
Caffeine
The metabolism of Imiquimod can be decreased when combined with Caffeine.
Carbamazepine
The metabolism of Imiquimod can be increased when combined with Carbamazepine.
Ceritinib
The serum concentration of Imiquimod can be increased when it is combined with Ceritinib.
Citalopram
The metabolism of Imiquimod can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Imiquimod can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Imiquimod can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Imiquimod can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Imiquimod can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Imiquimod.
Crizotinib
The metabolism of Imiquimod can be decreased when combined with Crizotinib.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Imiquimod.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Imiquimod.
Cyclosporine
The metabolism of Imiquimod can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The serum concentration of Imiquimod can be decreased when it is combined with Cyproterone acetate.
Dabrafenib
The serum concentration of Imiquimod can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Imiquimod can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Imiquimod can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Imiquimod can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Imiquimod can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Imiquimod can be decreased when combined with Delavirdine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Imiquimod.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Imiquimod.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Imiquimod.
Digoxin
Digoxin may decrease the cardiotoxic activities of Imiquimod.
Dihydroergotamine
The metabolism of Imiquimod can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Imiquimod can be decreased when combined with Diltiazem.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Imiquimod.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Imiquimod.
Dothiepin
The metabolism of Imiquimod can be decreased when combined with Dosulepin.
Doxycycline
The metabolism of Imiquimod can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Imiquimod can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Imiquimod can be decreased when combined with Dronedarone.
Enzalutamide
The serum concentration of Imiquimod can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Imiquimod can be decreased when combined with Erythromycin.
Fingolimod
Imiquimod may increase the immunosuppressive activities of Fingolimod.
Fluconazole
The metabolism of Imiquimod can be decreased when combined with Fluconazole.
Fluvoxamine
The metabolism of Imiquimod can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Imiquimod can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Imiquimod can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Imiquimod can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Imiquimod can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Imiquimod can be increased when it is combined with Fusidic Acid.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Imiquimod is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Imiquimod is combined with Hepatitis B Vaccine (Recombinant).
Hypoxis hemerocallidea root extract
The serum concentration of Imiquimod can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Imiquimod can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Imiquimod can be decreased when combined with Imatinib.
Indinavir
The metabolism of Imiquimod can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Imiquimod can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Imiquimod can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Imiquimod can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Imiquimod can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Imiquimod can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Imiquimod can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Imiquimod can be decreased when combined with Ketoconazole.
Leflunomide
The risk or severity of adverse effects can be increased when Imiquimod is combined with Leflunomide.
Lidocaine
The metabolism of Imiquimod can be decreased when combined with Lidocaine.
Lopinavir
The metabolism of Imiquimod can be decreased when combined with Lopinavir.
Lovastatin
The metabolism of Imiquimod can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Imiquimod can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Imiquimod can be increased when combined with Lumacaftor.
Mexiletine
The metabolism of Imiquimod can be decreased when combined with Mexiletine.
Midostaurin
The metabolism of Imiquimod can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Imiquimod can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Imiquimod can be decreased when it is combined with Mitotane.
Natalizumab
The risk or severity of adverse effects can be increased when Imiquimod is combined with Natalizumab.
Nefazodone
The metabolism of Imiquimod can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Imiquimod can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Imiquimod can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Imiquimod can be increased when combined with Nevirapine.
Nilotinib
The metabolism of Imiquimod can be decreased when combined with Nilotinib.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Imiquimod.
Olaparib
The metabolism of Imiquimod can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Imiquimod can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Imiquimod.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Imiquimod.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Imiquimod.
Palbociclib
The serum concentration of Imiquimod can be increased when it is combined with Palbociclib.
Peginterferon Alfa-2b
The serum concentration of Imiquimod can be increased when it is combined with Peginterferon alfa-2b.
Pentobarbital
The metabolism of Imiquimod can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Imiquimod can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Imiquimod can be increased when combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Imiquimod.
Posaconazole
The metabolism of Imiquimod can be decreased when combined with Posaconazole.
Primidone
The metabolism of Imiquimod can be increased when combined with Primidone.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Imiquimod.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Imiquimod is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Imiquimod.
Ranolazine
The metabolism of Imiquimod can be decreased when combined with Ranolazine.
Rifabutin
The metabolism of Imiquimod can be increased when combined with Rifabutin.
Rifampin
The metabolism of Imiquimod can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Imiquimod can be increased when combined with Rifapentine.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Imiquimod.
Ropinirole
The metabolism of Imiquimod can be decreased when combined with Ropinirole.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Imiquimod is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Imiquimod is combined with Rubella virus vaccine.
Rucaparib
The metabolism of Imiquimod can be decreased when combined with Rucaparib.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Imiquimod is combined with Salmonella typhi ty21a live antigen.
Saquinavir
The metabolism of Imiquimod can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Imiquimod can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Imiquimod can be decreased when used in combination with Sarilumab.
Sildenafil
The metabolism of Imiquimod can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Imiquimod can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Imiquimod can be increased when it is combined with Simeprevir.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Imiquimod.
ST. JOHN'S WORT EXTRACT
The serum concentration of Imiquimod can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Imiquimod can be decreased when combined with Sulfisoxazole.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Imiquimod.
Telaprevir
The metabolism of Imiquimod can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Imiquimod can be decreased when combined with Telithromycin.
Tenofovir Disoproxil
The metabolism of Imiquimod can be decreased when combined with Tenofovir disoproxil.
Teriflunomide
The serum concentration of Imiquimod can be decreased when it is combined with Teriflunomide.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Imiquimod is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Theophylline
The metabolism of Imiquimod can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Imiquimod can be decreased when combined with Theophylline.
Ticlopidine
The metabolism of Imiquimod can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Imiquimod can be decreased when it is combined with Tocilizumab.
Tofacitinib
Imiquimod may increase the immunosuppressive activities of Tofacitinib.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Imiquimod.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Imiquimod is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Imiquimod is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Imiquimod is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vemurafenib
The serum concentration of Imiquimod can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Imiquimod can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Imiquimod can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Imiquimod can be decreased when combined with Voriconazole.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Imiquimod is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Imiquimod is combined with Yellow Fever Vaccine.
Ziprasidone
The metabolism of Imiquimod can be decreased when combined with Ziprasidone.
